Effect of StentBoost imaging guided percutaneous coronary intervention on mid-term angiographic and clinical outcomes

Dong Joo Oh, Cheol Ung Choi, Sun Won Kim, Sung Il Im, Jin Oh Na, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Seong Woo Han, Seung-Woon Rha, Chang Gyu Park, Hong Seog Seo

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Introduction: The gold standard for evaluating stent expansion after percutaneous coronary intervention (PCI) is intravascular ultrasound (IVUS). However, the routine use of this modality is costly and time consuming. StentBoost is a new imaging technique that improves fluoroscopy-based assessments of stent expansion. The purpose of this study was to evaluate the effect of StentBoost imaging-guided PCI on mid-term angiographic and clinical outcomes. Methods and results: A total of 870 consecutive patients were recruited (mean age: 64.34±11.61; men: 64.5%), all of whom underwent PCI with drug-eluting stents (DESs). The subjects were divided into a no StentBoost group (n=569 patients) and a StentBoost group (n=301 patients). The 6-month angiographic and 12-month clinical outcomes were compared between the two groups. At 1 month, clinical outcomeswere similar between the two groups. At 6 months, the StentBoost group had significantly lower rates of late loss (0.32±0.40 vs. 0.48±0.59; p=0.005) and binary restenosis (1.2% vs. 8.3%; p=0.029) compared with the no-StentBoost group. At 12 months, StentBoost group had significantly lower the incidence of target lesion revascularization (TLR) (1.7% vs. 7%; p=0.034) and TLR-major adverse cardiac events (6% vs. 13.2%; p=0.037) compared with the no-StentBoost group. Conclusion:We conclude that the routine clinical use of StentBoost during PCI can be useful, and results in better medium-term angiographic and clinical outcomes.

Original languageEnglish
Pages (from-to)1479-1484
Number of pages6
JournalInternational Journal of Cardiology
Volume168
Issue number2
DOIs
Publication statusPublished - 2013 Sep 30

Fingerprint

Percutaneous Coronary Intervention
Stents
Drug-Eluting Stents
Fluoroscopy
Incidence

Keywords

  • Clinical outcomes
  • Percutaneous coronary intervention
  • StentBoost

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Effect of StentBoost imaging guided percutaneous coronary intervention on mid-term angiographic and clinical outcomes. / Oh, Dong Joo; Choi, Cheol Ung; Kim, Sun Won; Im, Sung Il; Na, Jin Oh; Lim, Hong Euy; Kim, Jin Won; Kim, Eung Ju; Han, Seong Woo; Rha, Seung-Woon; Park, Chang Gyu; Seo, Hong Seog.

In: International Journal of Cardiology, Vol. 168, No. 2, 30.09.2013, p. 1479-1484.

Research output: Contribution to journalArticle

@article{19732c81d0f7499b95efe43385767257,
title = "Effect of StentBoost imaging guided percutaneous coronary intervention on mid-term angiographic and clinical outcomes",
abstract = "Introduction: The gold standard for evaluating stent expansion after percutaneous coronary intervention (PCI) is intravascular ultrasound (IVUS). However, the routine use of this modality is costly and time consuming. StentBoost is a new imaging technique that improves fluoroscopy-based assessments of stent expansion. The purpose of this study was to evaluate the effect of StentBoost imaging-guided PCI on mid-term angiographic and clinical outcomes. Methods and results: A total of 870 consecutive patients were recruited (mean age: 64.34±11.61; men: 64.5{\%}), all of whom underwent PCI with drug-eluting stents (DESs). The subjects were divided into a no StentBoost group (n=569 patients) and a StentBoost group (n=301 patients). The 6-month angiographic and 12-month clinical outcomes were compared between the two groups. At 1 month, clinical outcomeswere similar between the two groups. At 6 months, the StentBoost group had significantly lower rates of late loss (0.32±0.40 vs. 0.48±0.59; p=0.005) and binary restenosis (1.2{\%} vs. 8.3{\%}; p=0.029) compared with the no-StentBoost group. At 12 months, StentBoost group had significantly lower the incidence of target lesion revascularization (TLR) (1.7{\%} vs. 7{\%}; p=0.034) and TLR-major adverse cardiac events (6{\%} vs. 13.2{\%}; p=0.037) compared with the no-StentBoost group. Conclusion:We conclude that the routine clinical use of StentBoost during PCI can be useful, and results in better medium-term angiographic and clinical outcomes.",
keywords = "Clinical outcomes, Percutaneous coronary intervention, StentBoost",
author = "Oh, {Dong Joo} and Choi, {Cheol Ung} and Kim, {Sun Won} and Im, {Sung Il} and Na, {Jin Oh} and Lim, {Hong Euy} and Kim, {Jin Won} and Kim, {Eung Ju} and Han, {Seong Woo} and Seung-Woon Rha and Park, {Chang Gyu} and Seo, {Hong Seog}",
year = "2013",
month = "9",
day = "30",
doi = "10.1016/j.ijcard.2012.12.051",
language = "English",
volume = "168",
pages = "1479--1484",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Effect of StentBoost imaging guided percutaneous coronary intervention on mid-term angiographic and clinical outcomes

AU - Oh, Dong Joo

AU - Choi, Cheol Ung

AU - Kim, Sun Won

AU - Im, Sung Il

AU - Na, Jin Oh

AU - Lim, Hong Euy

AU - Kim, Jin Won

AU - Kim, Eung Ju

AU - Han, Seong Woo

AU - Rha, Seung-Woon

AU - Park, Chang Gyu

AU - Seo, Hong Seog

PY - 2013/9/30

Y1 - 2013/9/30

N2 - Introduction: The gold standard for evaluating stent expansion after percutaneous coronary intervention (PCI) is intravascular ultrasound (IVUS). However, the routine use of this modality is costly and time consuming. StentBoost is a new imaging technique that improves fluoroscopy-based assessments of stent expansion. The purpose of this study was to evaluate the effect of StentBoost imaging-guided PCI on mid-term angiographic and clinical outcomes. Methods and results: A total of 870 consecutive patients were recruited (mean age: 64.34±11.61; men: 64.5%), all of whom underwent PCI with drug-eluting stents (DESs). The subjects were divided into a no StentBoost group (n=569 patients) and a StentBoost group (n=301 patients). The 6-month angiographic and 12-month clinical outcomes were compared between the two groups. At 1 month, clinical outcomeswere similar between the two groups. At 6 months, the StentBoost group had significantly lower rates of late loss (0.32±0.40 vs. 0.48±0.59; p=0.005) and binary restenosis (1.2% vs. 8.3%; p=0.029) compared with the no-StentBoost group. At 12 months, StentBoost group had significantly lower the incidence of target lesion revascularization (TLR) (1.7% vs. 7%; p=0.034) and TLR-major adverse cardiac events (6% vs. 13.2%; p=0.037) compared with the no-StentBoost group. Conclusion:We conclude that the routine clinical use of StentBoost during PCI can be useful, and results in better medium-term angiographic and clinical outcomes.

AB - Introduction: The gold standard for evaluating stent expansion after percutaneous coronary intervention (PCI) is intravascular ultrasound (IVUS). However, the routine use of this modality is costly and time consuming. StentBoost is a new imaging technique that improves fluoroscopy-based assessments of stent expansion. The purpose of this study was to evaluate the effect of StentBoost imaging-guided PCI on mid-term angiographic and clinical outcomes. Methods and results: A total of 870 consecutive patients were recruited (mean age: 64.34±11.61; men: 64.5%), all of whom underwent PCI with drug-eluting stents (DESs). The subjects were divided into a no StentBoost group (n=569 patients) and a StentBoost group (n=301 patients). The 6-month angiographic and 12-month clinical outcomes were compared between the two groups. At 1 month, clinical outcomeswere similar between the two groups. At 6 months, the StentBoost group had significantly lower rates of late loss (0.32±0.40 vs. 0.48±0.59; p=0.005) and binary restenosis (1.2% vs. 8.3%; p=0.029) compared with the no-StentBoost group. At 12 months, StentBoost group had significantly lower the incidence of target lesion revascularization (TLR) (1.7% vs. 7%; p=0.034) and TLR-major adverse cardiac events (6% vs. 13.2%; p=0.037) compared with the no-StentBoost group. Conclusion:We conclude that the routine clinical use of StentBoost during PCI can be useful, and results in better medium-term angiographic and clinical outcomes.

KW - Clinical outcomes

KW - Percutaneous coronary intervention

KW - StentBoost

UR - http://www.scopus.com/inward/record.url?scp=84885293733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885293733&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2012.12.051

DO - 10.1016/j.ijcard.2012.12.051

M3 - Article

C2 - 23332899

AN - SCOPUS:84885293733

VL - 168

SP - 1479

EP - 1484

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 2

ER -